终于等到你：进口PD-1单抗开始在国内十五家医院做临床试验（附名单）

2016-04-03 MedSci MedSci原创

PD-1单抗，在过去一年是让多少肿瘤研究人员热血沸腾，让多少患者望穿秋水的“肿瘤抗生素”，终于在国内多家医院开始临床试验。动动手指转一下，也许便有一个生命在你不经意间得到救助。下面是Nivolumab（抗PD-1抗体）对比多西他赛治疗非小细胞肺癌III期临床试验参研医院名单，期待更多的适应症尽快开展，也期待国产PD1单抗早日进入临床。目前恒瑞医药PD-1单抗临床试验正式在中山大学肿

未标题-5.jpg

PD-1单抗，在过去一年是让多少肿瘤研究人员热血沸腾，让多少患者望穿秋水的“肿瘤抗生素”，终于在国内多家医院开始临床试验。动动手指转一下，也许便有一个生命在你不经意间得到救助。

下面是Nivolumab（抗PD-1抗体）对比多西他赛治疗非小细胞肺癌III期临床试验参研医院名单，期待更多的适应症尽快开展，也期待国产PD1单抗早日进入临床。目前恒瑞医药PD-1单抗临床试验正式在中山大学肿瘤防治中心启动，即将招募实体瘤患者。

姓名	吴一龙	职称	主任医师
电话	020-83800372	Email	syylwu@live.cn
邮政地址	广东省广州市中山二路106号伟伦楼14楼	邮编	510080
单位名称	广东省人民医院肿瘤中心肺科

各临床试验医院名单

序号	机构名称	主要研究者	城市	联系电话	门诊
1	广东省人民医院	吴一龙	广州		周三上午
2	吉林省肿瘤医院（吉林省长春市朝阳区湖光路1018号肿瘤科医生办公室）	程颖	长春	0431-85513379	周一上午
3	中山大学肿瘤防治中心（广州市东风东路651号中山肿瘤医院肿瘤内科）	张力	广州	020-87342288/020-87343458	周一周四上午
4	浙江省肿瘤医院（杭州市半山街道半山桥广济路38号，肿瘤内科）	张沂平	杭州		周一全天
5	浙江大学医学院附属第一医院（杭州市庆春路79号，呼吸内科）	周建英	杭州	021-22200000-3115	周一下午周四上午
6	浙江大学医学院附属邵逸夫医院（杭州庆春东路3号，呼吸内科）	应可净	杭州		周一上午周三上午庆春园区，周二上午下沙院区
7	复旦大学附属肿瘤医院（徐汇区东安路270号，肿瘤内科）	常建华	上海		周三上午
8	湘雅医院（长沙市湘雅路87号，呼吸科）	胡成平	长沙		周一全天周二上午
9	江苏省肿瘤医院（南京市百子亭42号，肿瘤内科）	冯继锋	南京		周二下午
10	北京胸科医院（北京市通州区北马厂97号，肿瘤内科）	刘喆	北京		周四上午
11	上海市胸科医院（上海市淮海西路241号，肺部肿瘤临床医学中心）	陆舜	上海		周一下午周四上午
12	上海市肺科医院（上海杨浦区政民路507号2号楼9F，肿瘤科）	周彩存	上海	021-65115006	周一周二上午
13	河南省肿瘤医院（东明路127号，内科）	马智勇	郑州	0371-65588420、0371-65587013	周一上午周三下午周五上午
14	中国人民解放军第三军医大学第三附属医院（大坪医院）（重庆市渝中区大坪长江支路10号，肿瘤科）	王东	中国		周一上午

更多疾病相关的受试者招募，请点击：受试者招募

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (21)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2017-09-22 1201f658m10(暂无昵称)

15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？

2 0
[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2017-09-19 坚强的土豆啊

今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛

123 0
[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2017-09-13 117.140.217.195

广西的可以参加临床实验吗

109 0
[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2017-09-12 忧优

湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢

94 0
[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2017-08-14 牛生

可以参加临床试验吗

107 0
[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2017-08-06 diiiin

请问上海的还需要招募临床病人吗？

55 0
[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2017-01-17 ms3297076796458174

#附名单#

68 0
[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2016-10-04 Carlos007

也是挺好的

48 0
[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2016-06-13 1def88e4m69(暂无匿称)

在其他领域中的应用呢

153 0
[GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
2016-06-13 1def88e4m69(暂无匿称)

没有安徽的吗

139 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科

终于等到你：进口PD-1单抗开始在国内十五家医院做临床试验（附名单）

相关资讯

科室

工具

服务